Urology · Summerville, SC
NPI
1356330260
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
295 A Midland Parkway, Ste 100
Summerville, SC, 29485
Phone (843) 871-5220
Groups this clinician bills Medicare through
Medicare paid, 2024
$646K
26,885 services
Medicare patients, 2024
950
Average age 75
Drug cost, 2024
$1.7M
2,534 prescriptions
Company payments, 2025
$5,249
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David W Brandli was code J0897 (injection, denosumab, 1 mg), 7,681 times for 24 patients. In total David W Brandli billed 26,885 services in 115 codes, and Medicare paid $646K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,681 | 24 | $20.63 | $158K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,392 | 739 | $11.17 | $16K |
| 99214 Office E&M - Established | Office | 1,064 | 532 | $84.72 | $90K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 756 | 12 | $45.61 | $34K |
| 81002 Clinical Chemistry | Office | 578 | 363 | $3.39 | $1,962 |
| 99213 Office E&M - Established | Office | 563 | 435 | $59.11 | $33K |
| 96372 Injection Administration | Office | 224 | 40 | $10.21 | $2,287 |
| 36415 Venipuncture Blood Collection | Office | 203 | 159 | $8.65 | $1,756 |
| 51798 Ultrasound - Nonspecific | Office | 190 | 149 | $7.47 | $1,419 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 166 | 38 | $46.88 | $7,782 |
| 99204 Office E&M - New | Office | 148 | 148 | $111.02 | $16K |
| 52000 Cystourethroscopy | Office | 111 | 97 | $163.01 | $18K |
| 99215 Office E&M - Established | Office | 100 | 96 | $125.49 | $13K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 81 | 37 | $35.77 | $2,897 |
| 51705 Other Organ Systems | Office | 54 | 16 | $67.93 | $3,668 |
By year: 2022 $336K for 26,278 services; 2023 $455K for 30,639 services; 2024 $646K for 26,885 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 578 | 363 | $3.39 | $1,962 |
| 36415 Venipuncture Blood Collection | 203 | 159 | $8.65 | $1,756 |
Medicare prescription drug claims, 2024
In 2024, the drug David W Brandli prescribed most often to Medicare patients was Tamsulosin Hcl, with 625 prescriptions and refills. In total David W Brandli wrote 2,534 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 625 | 1,616 | 232 | $9,555 |
| Finasteride Generic | 338 | 942 | 111 | $7,107 |
| Myrbetriq Mirabegron | 140 | 256 | 49 | $113K |
| Testosterone Cypionate Generic | 112 | 252 | 38 | $6,205 |
| Cephalexin Generic | 91 | 151 | 56 | $783 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 87 | 93 | 59 | $416 |
| Solifenacin Succinate Generic | 85 | 196 | 34 | $4,328 |
| Silodosin Generic | 67 | 147 | 26 | $7,523 |
| Levofloxacin Generic | 66 | 66 | 56 | $95.47 |
| Orgovyx Relugolix | 64 | 64 | Under 11 | $169K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 58 | 132 | 17 | $1,196 |
| Terazosin Hcl Generic | 55 | 133 | 14 | $744 |
| Potassium Citrate Er Potassium Citrate | 49 | 126 | 21 | $4,439 |
| Erleada Apalutamide | 48 | 48 | Under 11 | $571K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 47 | 47 | 39 | $321 |
Brand drugs: - claims; generic drugs: 2,118 claims; opioid claims: 56.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David W Brandli $5,249 ($5,249 in general payments such as food, travel and fees) from 25 companies. The largest payer was Pfizer Inc. with $1,557.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 4 | $1,557 |
| Procept Biorobotics Corporation PRCT | 3 | $1,231 |
| Astellas Pharma US Inc 4503.T | 6 | $668 |
| Janssen Biotech, Inc. JNJ | 6 | $264 |
| Olympus America Inc. | 7 | $195 |
| Boston Scientific Corporation BSX | 5 | $194 |
| Verity Pharmaceuticals Inc. | 10 | $173 |
| Ferring Pharmaceuticals Inc. | 4 | $137 |
| Bioprotect Medical, Inc. | 3 | $136 |
| Tolmar, Inc. | 4 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.